PrEP4All and the Public Interest Patent Law Institute led a letter of patient groups and civil society organizations to HHS and DOJ, urging the U.S. government to keep fighting the United States v. Gilead lawsuit on behalf of PrEP users and the American people.

“Advocates from communities who have been affected for over a decade by Gilead’s price gouging and profiteering off of government-owned HIV PrEP technology were deeply disappointed in the unexpected May 9th jury verdict,” the sign-on letter reads. “Gilead Sciences must be held accountable for its long-running infringement of the government’s patents on PrEP in order to deter future exploitation of government-funded discoveries.”

Read full letter here: 2023-05-30 Letter of P4A & PIPLI to DOJ & HHS